---
title: "抗癌物紫杉醇的发育路，还看ALDH2的介导帮助"
date: 2023-10-19T23:41:50Z
draft: ["false"]
tags: [
  "fetched",
  "英拜生物"
]
categories: ["Acdemic"]
---
抗癌物紫杉醇的发育路，还看ALDH2的介导帮助 by 英拜生物
------
<div><section><img data-ratio="0.10344827586206896" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/z5NrhAz6sATRssMQBciaLchEribdmpG1G8ekNRN1FY8ibVCLkJgpg0T7gBex84dCmrUX4rj74Jv9ZFjmSV9GxIic1g/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-w="580" src="https://mmbiz.qpic.cn/mmbiz_jpg/z5NrhAz6sATRssMQBciaLchEribdmpG1G8ekNRN1FY8ibVCLkJgpg0T7gBex84dCmrUX4rj74Jv9ZFjmSV9GxIic1g/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><p><span><span>紫杉醇是治疗非小细胞肺癌的主要手段，其耐药性严重影响病患的生存。然而，其内在机制和潜在的反转策略还需要进一步探索。本研究探讨了</span><span lang="EN-US">ALDH2</span><span>在非小细胞肺癌</span><span lang="EN-US">PTX</span><span>的耐药中的功能作用、临床意义及异常调控机制。并通过一系列研究证明了</span><span lang="EN-US">ALDH2</span><span>能帮助预测病患对</span><span lang="EN-US">PTX</span><span>治疗的反应，</span><span lang="EN-US">ALDH2</span><span>抑制在临床上是一种克服</span><span lang="EN-US">PTX</span><span>耐药的有前途的策略。本研究于</span><span lang="EN-US">2022</span><span>年</span><span lang="EN-US">4</span><span>月发表在《</span></span><span>MolecularCancer</span><span>》</span><span><span lang="EN-US">IF</span><span>：</span><span lang="EN-US">41.444</span></span><span>期刊上。</span></p><section><span><strong><span>技术路线：</span></strong></span></section><section><img data-galleryid="" data-ratio="0.6498194945848376" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuPcn2GFzjPmYJVZA3D0VlN5Pak81O3yzia2yZwJ3c4icV6cxA3fQEzl6g/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuPcn2GFzjPmYJVZA3D0VlN5Pak81O3yzia2yZwJ3c4icV6cxA3fQEzl6g/640?wx_fmt=png"></section><section><span><strong><span>主要研究结果：</span></strong></span></section><ol><li><section><span><strong><span lang="EN-US">1.<span> </span></span></strong><strong><span lang="EN-US">ALDH2</span></strong></span><span><strong><span>在</span></strong><strong><span lang="EN-US">NSCLC</span></strong><strong><span>细胞中被鉴定为紫杉醇耐药相关基因</span></strong><strong><span>。</span></strong></span></section></li></ol><p><span><span>作者对</span><span lang="EN-US">NCI-H460</span><span>和</span><span lang="EN-US">NCI-H460/PTX</span><span>细胞进行了基因芯片分析，研究差异表达的基因。通路分析显示，与茎干和耐药相关的通路显著富集，表明在肺癌中，茎干的变化包含在</span><span lang="EN-US">PTX</span><span>的耐药中（图</span><span lang="EN-US">1A</span><span>）。接下来，作者进一步分析了</span><span lang="EN-US">NSCLC</span><span>细胞和</span><span lang="EN-US">NSCLC/PTX</span><span>细胞的生物学特征。克隆形成实验、球体形成实验和</span><span lang="EN-US">Transwell</span><span>迁移实验表明</span><span lang="EN-US">NSCLC/PTX</span><span>细胞的自我更新和迁移的能力比</span><span lang="EN-US">NSCLC</span><span>细胞更强（图</span><span lang="EN-US">1B</span><span>）。以上所有结果表明，</span><span lang="EN-US">NSCLC/PTX</span><span>细胞的生物样特征增强。然后，作者分析了干细胞转录因子的蛋白表达。结果表明</span><span lang="EN-US">Sox2</span><span>、</span><span lang="EN-US">Nanog</span><span>和</span><span lang="EN-US">Oct4</span><span>在</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中的表达比在</span></span><span>NSCLC</span><span><span>细胞中的更高（图</span><span lang="EN-US">1C</span><span>）。</span></span></p><p><span><span>作者发现，在</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中</span><span lang="EN-US">ALDH</span><span>活性明显高于</span><span lang="EN-US">NSCLC</span><span>细胞（图</span><span lang="EN-US">1D</span><span>）。在</span><span lang="EN-US">ALDH</span><span>亚型中，</span><span lang="EN-US">ALDH2</span><span>在</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中的蛋白表达高于</span><span lang="EN-US">NSCLC</span><span>（图</span><span lang="EN-US">1E</span><span>）。作者利用</span><span lang="EN-US">CCLE</span><span>和</span><span lang="EN-US">GDSC</span><span>数据库分析</span><span lang="EN-US">ALDH2</span><span>与肺癌</span><span lang="EN-US">PTX</span><span>之间的关系。结果表明，</span><span lang="EN-US">ALDH2</span><span>的表达水平与对</span><span lang="EN-US">PTX</span><span>的敏感性线性相关。</span><span lang="EN-US">ALDH2</span><span>表达水平越高，细胞对</span><span lang="EN-US">PTX</span><span>的敏感性越低（图</span><span lang="EN-US">1F</span><span>）。作者测定了</span><span lang="EN-US">46</span><span>例</span><span lang="EN-US">NSCLC</span><span>患者</span><span lang="EN-US">PTX</span><span>治疗后组织标本中</span><span lang="EN-US">ALDH2</span><span>的表达水平，证实</span><span lang="EN-US">ALDH2</span><span>与</span><span lang="EN-US">NSCLC</span><span>患者</span><span lang="EN-US">PTX</span><span>敏感性的关系。结果表明，与低</span><span lang="EN-US">ALDH2</span><span>组相比，</span><span lang="EN-US">ALDH2</span><span>蛋白高表达水平与整体存活率差显著相关（图</span><span lang="EN-US">1G</span><span>）。综上所述，</span></span><span><span lang="EN-US">ALDH2</span><span>在</span><span lang="EN-US">NSCLC</span><span>细胞的成茎特性积累和</span><span lang="EN-US">PTX</span><span>耐药过程中起重要作用</span></span><span>。</span></p><section><img data-galleryid="" data-ratio="0.7888086642599278" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmub9UNh29iaUHhUUQC4Kgp7FjqibbxBhNuXHntqgNHAvbxOMsQuFpYyC1Q/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmub9UNh29iaUHhUUQC4Kgp7FjqibbxBhNuXHntqgNHAvbxOMsQuFpYyC1Q/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">1 </span><span>非小细胞肺癌紫杉醇耐药相关基因</span><span lang="EN-US">ALDH2</span><span>的鉴定</span><strong></strong></span></section><section><span><strong><span>2.当ALDH2在NSCLC细胞中受到药物抑制剂或基因干预时，PTX的疗效会发生变化。</span></strong></span></section><p><span><span>作者敲低</span><span lang="EN-US">ALDH2</span><span>后</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中</span><span lang="EN-US">PTX</span><span>的疗效显著升高，而过表达</span><span lang="EN-US">ALDH2</span><span>的</span><span lang="EN-US">NSCLC</span><span>细胞中</span><span lang="EN-US">PTX</span><span>的疗效显著降低（图</span><span lang="EN-US">2A-B</span><span>）。作者敲除</span><span lang="EN-US">ALDH2</span><span>后，</span><span lang="EN-US">NSCLC/PTX</span><span>细胞迁移和自我更新能力明显下降（图</span><span lang="EN-US">2C</span><span>）。过表达</span><span lang="EN-US">ALDH2</span><span>后</span><span lang="EN-US">NSCLC</span><span>细胞的迁移和自我更新能力明显增强（图</span><span lang="EN-US">2D</span><span>）。</span><span lang="EN-US">ALDH2</span><span>特异性抑制剂</span><span lang="EN-US">DZN</span><span>在非细胞毒性浓度下显著抑制</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中</span><span lang="EN-US">ALDH</span><span>活性。此外，在非细胞毒性浓度下，</span><span lang="EN-US">DZN</span><span>联合</span><span lang="EN-US">PTX</span><span>可显著增加</span><span lang="EN-US">NSCLC/PTX</span><span>细胞对</span><span lang="EN-US">PTX</span><span>的敏感性（图</span><span lang="EN-US">2E</span><span>）。作者暂时沉默</span><span lang="EN-US">ALDH2</span><span>和其他</span><span lang="EN-US">CSCs</span><span>相关的</span><span lang="EN-US">ALDH</span><span>亚型（</span><span lang="EN-US">ALDH1A1</span><span>和</span><span lang="EN-US">ALDH3A1</span><span>），并测定</span><span lang="EN-US">NSCLC/PTX</span><span>细胞对</span><span lang="EN-US">PTX</span><span>的敏感性。结果表明，其他</span><span lang="EN-US">ALDH</span><span>亚型的瞬时沉默对</span><span lang="EN-US">PTX</span><span>敏感性无显著影响。但当</span><span lang="EN-US">ALDH2</span><span>瞬时沉默后，</span><span lang="EN-US">NSCLC/PTX</span><span>细胞对</span><span lang="EN-US">PTX</span><span>的敏感性明显增强（图</span><span lang="EN-US">2F</span><span>）。综合以上结果，说明</span><span lang="EN-US">ALDH2</span><span>是与</span><span lang="EN-US">PTX</span><span>耐药相关的重要</span><span lang="EN-US">ALDH</span><span>亚型。</span></span></p><p><span><span>研究通过慢病毒转染，分别建立了单独表达荧光素酶（空载体组）或荧光素酶</span><span lang="EN-US">+ALDH2</span><span>（</span><span lang="EN-US">ALDH2</span><span>过表达组）的</span><span lang="EN-US">NCI-H1299</span><span>和</span><span lang="EN-US">NCI-H460</span><span>细胞。然后通过尾静脉注射</span><span lang="EN-US">Balb/c-nu</span><span>小鼠细胞。结果表明，注射</span><span lang="EN-US">ALDH2</span><span>过表达细胞的小鼠肺、脑和骨转移率均高于空载体组（图</span><span lang="EN-US">2G</span><span>）。此外，体内数据显示，</span><span lang="EN-US">ALDH2</span><span>过表达的</span><span lang="EN-US">NCI-H1299</span><span>异种移植瘤对</span><span lang="EN-US">PTX</span><span>的耐药性（抑制率</span><span lang="EN-US">39.36%</span><span>）高于未过表达</span><span lang="EN-US">ALDH2</span><span>的</span><span lang="EN-US">NCI-H1299</span><span>异种移植瘤（抑制率</span><span lang="EN-US">53.19%</span><span>）（图</span><span lang="EN-US">2H</span><span>）。同样，在</span><span lang="EN-US">NCIH460</span><span>异种移植瘤模型中也得出了此结论。综合以上结果，</span></span><span><span>说明</span><span lang="EN-US">ALDH2</span><span>与体内</span><span lang="EN-US">PTX</span><span>耐药有关</span></span><span>。</span></p><section><img data-galleryid="" data-ratio="1.1064981949458483" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuv7qQFhzrD4A53Yiasr2V8PTQejcaRgb4CUibnXu3alDSE8WPSONKquSg/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuv7qQFhzrD4A53Yiasr2V8PTQejcaRgb4CUibnXu3alDSE8WPSONKquSg/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">2 </span><span>当</span><span lang="EN-US">ALDH2</span><span>通过药物或基因干预调控</span><span lang="EN-US">NSCLC</span><span>细胞时，</span><span lang="EN-US">PTX</span><span>的疗效会发生改变</span></span></section><ol><li><section><span><strong><span lang="EN-US">3.<span> </span></span></strong><strong><span lang="EN-US">NFYA</span></strong><strong><span>转录因子参与</span></strong><strong><span lang="EN-US">ALDH2</span></strong><strong><span>转录的激活。</span></strong></span></section></li></ol><p><span><span>作者们分析了</span><span lang="EN-US">ALDH2</span><span>的启动子区域，并根据</span><span lang="EN-US">PROMO</span><span>、</span><span lang="EN-US">JASPAR</span><span>等生物信息学数据库预测了转录因子结合位点。结果发现转录因子</span><span lang="EN-US">NFYA</span><span>和</span><span lang="EN-US">HNF4A</span><span>存在多个结合位点（图</span><span lang="EN-US">3A</span><span>）。接下来，作者们采用双荧光素酶报告基因检测方法测定</span><span lang="EN-US">NSCLC</span><span>和</span><span lang="EN-US">NSCLC/PTX</span><span>中的报告基因活性。在</span><span lang="EN-US">NSCLC</span><span>细胞和</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中均见到类似的转录活性模式。其中包含一个</span><span lang="EN-US">NFYA</span><span>结合位点的</span><span lang="EN-US">P3</span><span>区在所检测的</span><span lang="EN-US">4</span><span>种细胞系中活性最高（图</span><span lang="EN-US">3B</span><span>）。这表明</span><span lang="EN-US">NFYA</span><span>可能是</span><span lang="EN-US">ALDH2</span><span>启动子的转录激活因子。接下来，作者们测定了转录因子</span><span lang="EN-US">NFYA</span><span>和</span><span lang="EN-US">HNF4A</span><span>在</span><span lang="EN-US">NSCLC</span><span>和</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中的蛋白表达水平。</span><span lang="EN-US">NSCLC/PTX</span><span>细胞</span><span lang="EN-US">NFYA</span><span>和</span><span lang="EN-US">HNF4A</span><span>蛋白水平高于</span><span lang="EN-US">NSCLC</span><span>细胞（图</span><span lang="EN-US">3C</span><span>）。进一步，作者们利用双荧光素酶报告法研究了转录因子</span><span lang="EN-US">NFYA</span><span>和</span><span lang="EN-US">HNF4A</span><span>对</span><span lang="EN-US">ALDH2</span><span>启动子的调控能力。结果表明，在转染过表达</span><span lang="EN-US">NFYA</span><span>或</span><span lang="EN-US">HNF4A</span><span>质粒的</span><span lang="EN-US">NSCLC</span><span>和</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中，</span><span lang="EN-US">ALDH2</span><span>启动子活性明显增强（图</span><span lang="EN-US">3D</span><span>）。这为这两种转录因子在</span><span lang="EN-US">ALDH2</span><span>转录调控中的关键作用提供了进一步的证据。</span></span></p><p><span><span>作者对</span><span lang="EN-US">ALDH2</span><span>启动子内的</span><span lang="EN-US">NFYA</span><span>和</span><span lang="EN-US">HNF4A</span><span>结合位点进行突变，构建了报告基因</span><span lang="EN-US">pGL3- ALDH2 – NFYA - M1/M2</span><span>和</span><span lang="EN-US">pGL3- ALDH2 - HNF4AM1/M2/M3</span><span>，并测定了这些报告基因在细胞中的转录活性。与其他启动子突变质粒相比，</span><span lang="EN-US">pGL3- ALDH2 - NFYA - M1</span><span>在</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中的荧光素酶活性明显降低，表明</span><span lang="EN-US">ALDH2</span><span>启动子的转录激活依赖于</span><span lang="EN-US">NFYA</span><span>（图</span><span lang="EN-US">3E</span><span>）。接下来构建稳定敲低</span><span lang="EN-US">NFYA</span><span>的</span><span lang="EN-US">NSCLC/PTX</span><span>细胞，并测定了</span><span lang="EN-US">ALDH2</span><span>蛋白水平。结果表明，</span><span lang="EN-US">ALDH2</span><span>蛋白在这些细胞中的表达水平降低（图</span><span lang="EN-US">3F</span><span>）。此外，拯救</span><span lang="EN-US">NFYA</span><span>表达时，</span><span lang="EN-US">ALDH2</span><span>蛋白表达水平升高（图</span><span lang="EN-US">3F</span><span>）。为明确</span><span lang="EN-US">NFYA</span><span>与</span><span lang="EN-US">ALDH2</span><span>之间的关系，作者采用免疫组织化学方法检测</span><span lang="EN-US">49</span><span>例</span><span lang="EN-US">PTX</span><span>治疗的</span><span lang="EN-US">NSCLC</span><span>患者组织标本中</span><span lang="EN-US">NFYA</span><span>和</span><span lang="EN-US">ALDH2</span><span>的表达水平。结果显示，</span><span lang="EN-US">80% NFYA</span><span>高表达患者（</span><span lang="EN-US">n= 20</span><span>）为高</span><span lang="EN-US">ALDH2</span><span>表达组（</span><span lang="EN-US">n= 25</span><span>），</span><span lang="EN-US">54% NFYA</span><span>低表达患者（</span><span lang="EN-US">n= 13</span><span>）为低</span><span lang="EN-US">ALDH2</span><span>表达组（</span><span lang="EN-US">n= 24</span><span>）。由此可见，</span><span lang="EN-US">PTX</span><span>治疗</span><span lang="EN-US">NSCLC</span><span>患者</span><span lang="EN-US">NFYA</span><span>表达与</span><span lang="EN-US">ALDH2</span><span>表达呈正相关（图</span><span lang="EN-US">3G</span><span>）。综合以上结果，</span></span><span><span>证明了</span><span lang="EN-US">NFYA</span><span>是</span><span lang="EN-US">ALDH2</span><span>重要的转录激活因子。</span></span></p><section><img data-galleryid="" data-ratio="1.1064981949458483" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuwesjNK5o8unJFI4IWZ3jWfh1D2KbZouWLbH3y8dMM2DuiaFLic60X0fw/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuwesjNK5o8unJFI4IWZ3jWfh1D2KbZouWLbH3y8dMM2DuiaFLic60X0fw/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">3NFYA</span><span>转录因子参与</span><span lang="EN-US">ALDH2</span><span>转录的激活</span></span></section><ol><li><section><span><strong><span lang="EN-US">4.<span> </span></span></strong><strong><span lang="EN-US">ALDH2</span></strong><strong><span>的转录激活受</span></strong><strong><span lang="EN-US">NFYA</span></strong><strong><span>和</span></strong><strong><span lang="EN-US">EHMT2</span></strong><strong><span>的协作调控。</span></strong></span></section></li></ol><p><span><span>基因芯片结果显示，与</span><span lang="EN-US">NSCLC</span><span>细胞相比，</span><span lang="EN-US">NCI-H460/PTX</span><span>细胞中一些表观遗传学酶的表达发生了改变（图</span><span lang="EN-US">4A</span><span>）。因此，作者测定了一系列表观遗传酶抑制剂处理的</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中</span><span lang="EN-US">ALDH2</span><span>蛋白水平。结果表明，抑制</span><span lang="EN-US">EHMT2</span><span>（组蛋白赖氨酸甲基转移酶</span><span lang="EN-US">2</span><span>）的</span><span lang="EN-US">UNC0638</span><span>在</span><span lang="EN-US">NSCLC/PTX</span><span>细胞和</span><span lang="EN-US">NSCLC</span><span>细胞中明显上调</span><span lang="EN-US">ALDH2</span><span>（图</span><span lang="EN-US">4B</span><span>）。</span><span lang="EN-US">EHMT2</span><span>增加</span><span lang="EN-US">H3K9me2</span><span>水平，对转录有抑制作用。研究推测，当</span><span lang="EN-US">EHMT2</span><span>被抑制时，</span><span lang="EN-US">ALDH2</span><span>的表达会上调。作者们又测定了另外三种</span><span lang="EN-US">EHMT2</span><span>抑制剂（</span><span lang="EN-US">UNC0638</span><span>、</span><span lang="EN-US">UNC0642</span><span>、</span><span lang="EN-US">UNC0631</span><span>）和</span><span lang="EN-US">JMJD</span><span>抑制剂</span><span lang="EN-US">JIB04</span><span>处理的</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中</span><span lang="EN-US">ALDH2</span><span>蛋白水平。结果发现</span><span lang="EN-US">EHMT2</span><span>抑制剂上调</span><span lang="EN-US">ALDH2</span><span>蛋白表达，</span><span lang="EN-US">JIB04</span><span>具有下调作用（图</span><span lang="EN-US">4C</span><span>）。</span><span>这些结果说明</span><span lang="EN-US">EHMT2</span><span>和</span><span lang="EN-US">JMJD</span><span>通过表观遗传学机制调控</span><span lang="EN-US">ALDH2</span><span>。</span></span></p><p><span><span>作者们在</span><span lang="EN-US">UNC0638</span><span>、</span><span lang="EN-US">UNCC0642</span><span>和</span><span lang="EN-US">JIB04</span><span>处理的</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中过表达</span><span lang="EN-US">NFYA</span><span>。结果表明，当</span><span lang="EN-US">NFYA</span><span>过表达或</span><span lang="EN-US">EHMT2</span><span>被抑制时，</span><span lang="EN-US">ALDH2</span><span>启动子活性显著升高；此外，</span><span lang="EN-US">NFYA</span><span>过表达和</span><span lang="EN-US">EHMT2</span><span>抑制共同作用于</span><span lang="EN-US">ALDH2</span><span>的上调（图</span><span lang="EN-US">4D-E</span><span>）。然后，作者在</span><span lang="EN-US">NCI-H460</span><span>和</span><span lang="EN-US">NCI-H460/PTX</span><span>细胞中，绘制了两个组蛋白标记（</span><span lang="EN-US">H3K9me2,Ac-H3</span><span>）在全基因组的图谱。结果表明，</span><span lang="EN-US">NCI-H460/PTX</span><span>中</span><span lang="EN-US">H3K9me2</span><span>峰活性染色质信号较低，</span><span lang="EN-US">Ac-H3</span><span>峰活性染色质信号较高（图</span><span lang="EN-US">4F</span><span>）。此外，研究还验证了与</span><span lang="EN-US">NCI-H460</span><span>相比，</span><span lang="EN-US">NCIH460/PTX</span><span>中</span><span lang="EN-US">ALDH2</span><span>启动子区</span><span lang="EN-US">H3K9me2</span><span>的积累减少，而</span><span lang="EN-US">Ac-H3</span><span>的积累则在</span><span lang="EN-US">ALDH2</span><span>启动子区（图</span><span lang="EN-US">4G</span><span>顶部和中部）增加。</span><span lang="EN-US">UNC0638</span><span>处理的</span><span lang="EN-US">NCIH460</span><span>细胞，</span><span lang="EN-US">NFYA</span><span>与</span><span lang="EN-US">ALDH2</span><span>启动子的结合能力增强，而</span><span lang="EN-US">JIB04</span><span>则相反（图</span><span lang="EN-US">4G</span><span>底）。总体而言，</span></span><span><span>这些结果提示</span><span lang="EN-US">NFYA</span><span>是</span><span lang="EN-US">ALDH2</span><span>的重要转录激活因子，</span><span lang="EN-US">EHMT2</span><span>和</span><span lang="EN-US">NFYA</span><span>在</span><span lang="EN-US">ALDH2</span><span>的调控中具有协同作用。</span></span></p><section><img data-galleryid="" data-ratio="0.9458483754512635" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuYp5bNVgIfT3c1kFTq41UW0RK5uvn5t7Znxb60j6dWQAiaHMRsMnZ86g/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuYp5bNVgIfT3c1kFTq41UW0RK5uvn5t7Znxb60j6dWQAiaHMRsMnZ86g/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">4ALDH2</span><span>的转录激活受</span><span lang="EN-US">NFYA</span><span>和</span><span lang="EN-US">EHMT2</span><span>的协作调控</span></span></section><ol><li><section><span><strong><span lang="EN-US">5.<span> </span></span></strong><strong><span lang="EN-US">ALDH2</span></strong><strong><span>通过</span></strong><strong><span lang="EN-US">RAS/RAF</span></strong><strong><span>通路介导紫杉醇的耐药性。</span></strong></span></section></li></ol><p><span><span>对转染</span><span lang="EN-US">ALDH2</span><span>或扰乱</span><span lang="EN-US">shRNA</span><span>的</span><span lang="EN-US">NCI-H460/PTX</span><span>细胞进行基因芯片分析，结果显示，稳定敲除</span><span lang="EN-US">ALDH2</span><span>后，</span><span lang="EN-US">NCI-H460/PTX</span><span>细胞中有许多基因差异表达；其中，</span><span lang="EN-US">511</span><span>个</span><span lang="EN-US">shALDH2</span><span>与</span><span lang="EN-US">Scramble</span><span>相比有所下降（图</span><span lang="EN-US">5A</span><span>）。与</span><span lang="EN-US">NCI-H460</span><span>相比，</span><span lang="EN-US">NCI-H460/PTX</span><span>上调基因间存在富集基因；与</span><span lang="EN-US">Scramble</span><span>相比，</span><span lang="EN-US">ALDH2shRNA</span><span>转染</span><span lang="EN-US">NCI-H460/PTX</span><span>下调基因间存在富集基因（图</span><span lang="EN-US">5B</span><span>）。通路分析显示</span><span lang="EN-US">TGFβ</span><span>通路、</span><span lang="EN-US">RAF</span><span>通路、</span><span lang="EN-US">EMT</span><span>通路等明显富集（图</span><span lang="EN-US">5C</span><span>），表明这些通路可能参与</span><span lang="EN-US">ALDH2</span><span>介导的肺癌</span><span lang="EN-US">PTX</span><span>耐药。接下来，作者们研究了</span><span lang="EN-US">RAS/RAF</span><span>信号通路相关蛋白的表达情况，发现与</span><span lang="EN-US">Scramble</span><span>组相比，</span><span lang="EN-US">ALDH2</span><span>敲低的</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中</span><span lang="EN-US">RAS/RAF</span><span>信号通路相关蛋白的表达水平持续下降（图</span><span lang="EN-US">5D</span><span>）。因此，我们推测</span><span lang="EN-US">RAS/RAF</span><span>信号通路参与了</span><span lang="EN-US">ALDH2</span><span>介导的紫杉醇耐药。然后，作者们过表达</span><span lang="EN-US">KRAS</span><span>和</span><span lang="EN-US">RAF1</span><span>，并测定</span><span lang="EN-US">PTX</span><span>在</span><span lang="EN-US">ALDH2</span><span>敲除</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中的疗效。结果表明，在</span><span lang="EN-US">ALDH2</span><span>敲低的</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中过表达</span><span lang="EN-US">KRAS</span><span>和</span><span lang="EN-US">RAF1</span><span>后，</span><span lang="EN-US">PTX</span><span>的疗效下降（图</span><span lang="EN-US">5E-F</span><span>）。综合以上结果，</span></span><span><span>证明</span><span lang="EN-US">RAS/RAF</span><span>信号通路参与了</span><span lang="EN-US">ALDH2</span><span>介导的</span><span lang="EN-US">PTX</span><span>抗性。</span></span></p><section><img data-galleryid="" data-ratio="0.8068592057761733" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuibOcSicYaxFYabicvic14u0c4jib8gE93YwTWKbiaj3XZdoicDz7Uc00DCwVQ/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuibOcSicYaxFYabicvic14u0c4jib8gE93YwTWKbiaj3XZdoicDz7Uc00DCwVQ/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">5 </span><span>敲低</span><span lang="EN-US">ALDH2</span><span>可抑制</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中的</span><span lang="EN-US">RAS/RAF</span><span>通路</span></span></section><ol><li><section><span><strong><span lang="EN-US">6.<span>  </span></span></strong><strong><span lang="EN-US">ALDH2</span></strong><strong><span>的药理抑制使体内外的</span></strong><strong><span lang="EN-US">NSCLC/PTX</span></strong><strong><span>细胞对紫杉醇敏感。</span></strong></span></section></li></ol><p><span><span lang="EN-US">DZN</span><span>是</span><span lang="EN-US">ALDH2</span><span>的特异性抑制剂，</span><span lang="EN-US">DSF</span><span>是</span><span lang="EN-US">ALDH2</span><span>的非特异性抑制剂。为了验证</span><span lang="EN-US">DZN+ PTX</span><span>或</span><span lang="EN-US">DSF+ PTX</span><span>对</span><span lang="EN-US">NSCLC/PTX</span><span>细胞的生长抑制具有协同作用，作者采用</span><span lang="EN-US">NCI-H460/PTX</span><span>异种移植模型，测定其体内靶向</span><span lang="EN-US">ALDH2</span><span>的抑制效果（图</span><span lang="EN-US">6A</span><span>）。结果显示，</span><span lang="EN-US">DZN+ PTX</span><span>组和</span><span lang="EN-US">DSF+ PTX</span><span>组肿瘤体积明显小于</span><span lang="EN-US">PTX</span><span>单独组（图</span><span lang="EN-US">6B-C</span><span>）。</span><span lang="EN-US">DZN+ PTX</span><span>组肿瘤重量明显低于单纯</span><span lang="EN-US">PTX</span><span>（图</span><span lang="EN-US">6D</span><span>）。这些结果表明，靶向抑制</span><span lang="EN-US">ALDH2</span><span>逆转了</span><span lang="EN-US">PTX</span><span>抗性。</span><span lang="EN-US">TUNEL</span><span>染色证实，与单纯</span><span lang="EN-US">PTX</span><span>相比，</span><span lang="EN-US">DZN+ PTX</span><span>和</span><span lang="EN-US">DSF+ PTX</span><span>显著增加肿瘤组织细胞凋亡水平（图</span><span lang="EN-US">6E</span><span>）。此外，</span><span lang="EN-US">Westernblot</span><span>结果证实</span><span lang="EN-US">PTX</span><span>联合</span><span lang="EN-US">ALDH2</span><span>抑制剂较单独</span><span lang="EN-US">PTX</span><span>能抑制</span><span lang="EN-US">Erk1/2</span><span>和</span><span lang="EN-US">MEK1/2</span><span>磷酸化（图</span><span lang="EN-US">6F</span><span>），免疫组化结果也证实</span><span lang="EN-US">PTX</span><span>联合</span><span lang="EN-US">ALDH2</span><span>抑制剂较单独</span><span lang="EN-US">PTX</span><span>能抑制</span><span lang="EN-US">ERK1/2</span><span>磷酸化（图</span><span lang="EN-US">6G</span><span>）。以上数据表明，</span></span><span><span lang="EN-US">DZN</span><span>或</span><span lang="EN-US">DSF</span><span>对</span><span lang="EN-US">ALDH2</span><span>的药理学抑制作用可通过诱导细胞凋亡和抑制</span><span lang="EN-US">RAS/RAF</span><span>信号通路逆转</span><span lang="EN-US">NCI-H460/PTX</span><span>异种移植模型的</span><span lang="EN-US">PTX</span><span>耐药性</span></span><span>。</span></p><section><img data-galleryid="" data-ratio="0.7870036101083032" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuH76Zla50iaRxRbcEQkX6IfoSRtcdaPkPpQlwscTZeDDia00MX0ia5LCMg/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuH76Zla50iaRxRbcEQkX6IfoSRtcdaPkPpQlwscTZeDDia00MX0ia5LCMg/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">6DZN</span><span>和</span><span lang="EN-US">DSF</span><span>使体内</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中紫杉醇的耐药显著下降</span></span></section><ol><li><section><span><strong><span lang="EN-US">7.<span> </span></span></strong><strong><span lang="EN-US">ALDH2</span></strong><strong><span>的表观遗传下调使体内外</span></strong><strong><span lang="EN-US">NSCLC/PTX</span></strong><strong><span>细胞中紫杉醇的耐药性下降。</span></strong></span></section></li></ol><p><span><span>本实验构建了</span><span lang="EN-US">NCI-H460/PTX</span><span>异种移植瘤模型，研究</span><span lang="EN-US">JIB04</span><span>和</span><span lang="EN-US">PTX</span><span>联合应用能否逆转</span><span lang="EN-US">PTX</span><span>耐药（图</span><span lang="EN-US">7A</span><span>）。在本模型中，</span><span lang="EN-US">JIB04+ PTX</span><span>组与</span><span lang="EN-US">PTX</span><span>单独组相比，明显抑制了相对肿瘤体积和肿瘤重量（图</span><span lang="EN-US">7B</span><span>和</span><span lang="EN-US">C</span><span>）。以上结果表明，</span><span lang="EN-US">JIB04</span><span>与</span><span lang="EN-US">PTX</span><span>合用，提高了</span><span lang="EN-US">PTX</span><span>的抗肿瘤作用，逆转了</span><span lang="EN-US">PTX</span><span>的耐药性。在</span><span lang="EN-US">NCI-H460/PTX</span><span>肿瘤组织中，</span><span lang="EN-US">Westernblot</span><span>和免疫化学进一步证实</span><span lang="EN-US">JIB04</span><span>下调</span><span lang="EN-US">ALDH2</span><span>（图</span><span lang="EN-US">7D</span><span>和</span><span lang="EN-US">E</span><span>）。</span><span lang="EN-US">TUNEL</span><span>染色也证实</span><span lang="EN-US">JIB04+ PTX</span><span>显著增加肿瘤细胞的凋亡水平（图</span><span lang="EN-US">7F</span><span>）。总的来说，表明</span><span lang="EN-US">JIB04</span><span>与</span><span lang="EN-US">PTX</span><span>联合诱导</span><span lang="EN-US">PTX</span><span>耐药的</span><span lang="EN-US">NSCLC</span><span>移植瘤细胞凋亡。当用</span><span lang="EN-US">EHMT2</span><span>抑制剂</span><span lang="EN-US">UNC0642</span><span>替代</span><span lang="EN-US">DZN</span><span>上调</span><span lang="EN-US">ALDH2</span><span>表达时，肿瘤体积较其他两组增大（图</span><span lang="EN-US">7G</span><span>）。综上所述，</span></span><span><span lang="EN-US">ALDH2</span><span>的表达可通过表观遗传学途径调控，从而影响</span><span lang="EN-US">NSCLC</span><span>对</span><span lang="EN-US">PTX</span><span>的敏感性</span></span><span>。</span></p><section><img data-galleryid="" data-ratio="0.759927797833935" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuuo2YbpiaufuOp7MSvAndbGq7JJMiaUEPJ51JwpiaoWvS2qvwL2CNbiaK1A/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuuo2YbpiaufuOp7MSvAndbGq7JJMiaUEPJ51JwpiaoWvS2qvwL2CNbiaK1A/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">7JIB04</span><span>使体内</span><span lang="EN-US">NSCLC/PTX</span><span>细胞中紫杉醇的耐药显著下降</span></span></section><section><img data-galleryid="" data-ratio="0.6642599277978339" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuYo7XYhaKvuPWhVd6NPCo61iayTfBuVc4yicYxdxUiaxI4CSgWbC1owsUA/640?wx_fmt=png" data-type="png" data-w="554" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sATvBtWvnngbkbXZdQrPrnmuYo7XYhaKvuPWhVd6NPCo61iayTfBuVc4yicYxdxUiaxI4CSgWbC1owsUA/640?wx_fmt=png"></section><section><span><span>图</span><span lang="EN-US">8 </span><span>研究结果图</span></span></section><section><span><strong><span>结论</span></strong></span></section><p><span><span>本研究结果总结在一个示意图（图</span><span lang="EN-US">8</span><span>）。抑制</span><span lang="EN-US">EHMT2</span><span>和同时过表达</span><span lang="EN-US">NFYA</span><span>可上调</span><span lang="EN-US">ALDH2</span><span>的表达，该信号轴参与介导体内外对</span><span lang="EN-US">PTX</span><span>的耐药。从机制上讲，</span><span lang="EN-US">NFYA</span><span>是</span><span lang="EN-US">ALDH2</span><span>重要的转录激活因子，</span><span lang="EN-US">EHMT2</span><span>通过增加</span><span lang="EN-US">H3K9me2</span><span>水平使染色质致密化。抑制</span><span lang="EN-US">EHMT2</span><span>可促进</span><span lang="EN-US">NFYA</span><span>与</span><span lang="EN-US">ALDH2</span><span>启动子结合，从而激活</span><span lang="EN-US">ALDH2</span><span>的转录。</span><span lang="EN-US">DZN</span><span>、</span><span lang="EN-US">DSF</span><span>或</span><span lang="EN-US">JIB04</span><span>抑制或下调</span><span lang="EN-US">ALDH2</span><span>可增加</span><span lang="EN-US">PTX</span><span>对</span><span lang="EN-US">NSCLC/PTX</span><span>细胞或移植瘤的疗效，逆转</span><span lang="EN-US">PTX</span><span>耐药。本研究结果揭示了一种抑制或下调促瘤基因的新策略，可能为克服</span><span lang="EN-US">PTX</span><span>耐药提供了突破口。</span></span></p><section><span><strong><span>参考文献</span></strong></span></section><section><span>Wang W, Wang J, Liu S,Ren Y, Wang J, Liu S, Cui W, Jia L, Tang X, Yang J, Wu C, Wang L. (2022). AnEHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulatepaclitaxel resistance in lung cancer. Mol Cancer. 2022 Apr 27;21(1):106. doi:10.1186/s12943-022-01579-9.</span></section><section><span><img data-backh="77" data-backw="578" data-ratio="0.13203125" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sAQu28jic5Qh2a7Wxe5tgylYZ5n6LAWH639uACGA4IAHQUBLzfMkWpuPb7mDIh8ibPuGqXRmqXqmegWA/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="png" data-w="1280" src="https://mmbiz.qpic.cn/mmbiz_png/z5NrhAz6sAQu28jic5Qh2a7Wxe5tgylYZ5n6LAWH639uACGA4IAHQUBLzfMkWpuPb7mDIh8ibPuGqXRmqXqmegWA/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></span></section><ul><li><p><span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MjM5MjU0MDkxMQ==&amp;mid=2654531504&amp;idx=1&amp;sn=2aace4324dbb476998901fc8503cdb22&amp;chksm=bd68fe308a1f772698814b371277af66482aad8df0f919baa0f34fdf792bbf768b6c1283ff72&amp;scene=21#wechat_redirect" textvalue="缺氧诱导外泌体circPDK1通过调控miR-628-3p/BPTF轴和降解BIN1激活c-myc以促进胰腺癌糖酵解" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2">缺氧诱导外泌体circPDK1通过调控miR-628-3p/BPTF轴和降解BIN1激活c-myc以促进胰腺癌糖酵解</a><br></span></p></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MjM5MjU0MDkxMQ==&amp;mid=2654531615&amp;idx=1&amp;sn=86c6373be4b42aa334908814f62c48ae&amp;chksm=bd68e19f8a1f68893122c9d1467ea3fbbe0f533d50b509fab665c34ac587346b72ced7662a34&amp;scene=21#wechat_redirect" textvalue="新发现——铁死亡促进椎间盘退化症" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>新发现——铁死亡促进椎间盘退化症</span></a><br></p></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MjM5MjU0MDkxMQ==&amp;mid=2654531616&amp;idx=1&amp;sn=075c68aacaa087cb596be7393ecb2a76&amp;chksm=bd68e1a08a1f68b6f45b34c344f3472d6f49bc9ac5bb29d5370276f771ca29c170dc02a05f2b&amp;scene=21#wechat_redirect" textvalue="LiqBioer：人工管理的体液中癌症生物标志物数据库" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>LiqBioer：人工管理的体液中癌症生物标志物数据库</span></a><br></p></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MjM5MjU0MDkxMQ==&amp;mid=2654531619&amp;idx=1&amp;sn=8826cba373cabbf059c32e92546ff9e4&amp;chksm=bd68e1a38a1f68b5c966d8f09386ca24ec783b37fafe3820a6f2fa1242027b28e03b17ec0b10&amp;scene=21#wechat_redirect" textvalue="lncRNA-IUR1通过负向调控stat5介导的GATA3表达来抑制Bcr-Abl诱导的肿瘤发生" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>lncRNA-IUR1通过负向调控stat5介导的GATA3表达来抑制Bcr-Abl诱导的肿瘤发生</span></a><br></p></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MjM5MjU0MDkxMQ==&amp;mid=2654531610&amp;idx=1&amp;sn=58ffec67fea9befb2b544a11c9155864&amp;chksm=bd68e19a8a1f688cc4b26ad3d7142c97c3494d0cc43830b20c6f8d524fc7046a46de41fd724e&amp;scene=21#wechat_redirect" textvalue="不一样的研究视角——乳酸受体HCAR1促进神经细胞增殖改善新生儿脑卒中" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>不一样的研究视角——乳酸受体HCAR1促进神经细胞增殖改善新生儿脑卒中</span></a><br></p></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MjM5MjU0MDkxMQ==&amp;mid=2654531612&amp;idx=1&amp;sn=dd59d62418aa61736229b1fc2e6a41b4&amp;chksm=bd68e19c8a1f688a2db80bd514292208c2681e5f7b223b1ffe57cc1b3bbaa8ec0aee10e4e29f&amp;scene=21#wechat_redirect" textvalue="抑制肝癌的咽喉，还得看circRNAs的表演" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>抑制肝癌的咽喉，还得看circRNAs的表演</span></a></p></li></ul><section><strong><span>谢</span></strong><strong><span><span data-raw-text="谢" data-textnode-index-1662346638861="799" data-index-1662346638861="3784">谢</span><span data-raw-text="！" data-textnode-index-1662346638861="799" data-index-1662346638861="3785">！</span></span></strong></section><section><strong><span> </span></strong><strong><span> </span></strong><br></section><section><section><section><span><strong><span><span data-raw-text="英" data-textnode-index-1663548143272="909" data-index-1663548143272="4923">英</span><span data-raw-text="拜" data-textnode-index-1663548143272="909" data-index-1663548143272="4924">拜</span></span></strong><strong><span>生</span></strong><strong><span>物</span></strong></span></section></section><section><section><span><span data-raw-text="课" data-textnode-index-1651211151201="154" data-index-1651211151201="4519">课题设计与申报</span><span data-raw-text="整" data-textnode-index-1646285631674="76" data-index-1646285631674="3226"><span data-raw-text="|" data-textnode-index-1652076361465="25" data-index-1652076361465="549">|</span><span data-raw-text="分" data-textnode-index-1654764602169="70" data-index-1654764602169="5128"><span data-raw-text="分" data-textnode-index-1659001151199="18" data-index-1659001151199="359">分子</span><span data-raw-text="生" data-textnode-index-1659001151199="18" data-index-1659001151199="361">生物学实</span></span></span><span data-raw-text="细" data-textnode-index-1651211151201="177" data-index-1651211151201="4542">验|</span><span data-raw-text="细" data-textnode-index-1651211151201="177" data-index-1651211151201="4542"><span data-raw-text="细" data-textnode-index-1662346638861="812" data-index-1662346638861="3808"><span data-raw-text="细" data-textnode-index-1662551658614="624" data-index-1662551658614="4083">细</span><span data-raw-text="胞" data-textnode-index-1662551658614="625" data-index-1662551658614="4084">胞</span></span><span data-raw-text="|" data-textnode-index-1652076361465="36" data-index-1652076361465="567">功</span><span data-raw-text="能" data-textnode-index-1662346638861="814" data-index-1662346638861="3811">能</span><span data-raw-text="|" data-textnode-index-1652076361465="36" data-index-1652076361465="567"><span data-raw-text="|" data-textnode-index-1662346638861="815" data-index-1662346638861="3812">|</span><span data-raw-text="机" data-textnode-index-1662346638861="815" data-index-1662346638861="3813">机</span><span data-raw-text="制" data-textnode-index-1662346638861="815" data-index-1662346638861="3814">制</span><span data-raw-text="调" data-textnode-index-1662346638861="815" data-index-1662346638861="3815">调</span><span data-raw-text="控" data-textnode-index-1662346638861="815" data-index-1662346638861="3816">控</span><span>|多组学检测分析</span></span></span></span></section></section><section><br></section><section><section><section data-ele=""><section><section><section><section><section><section><section><img data-fileid="507042390" data-ratio="0.6583333333333333" data-src="https://mmbiz.qpic.cn/mmbiz/CItRLtZlHnDZbmxkcWD2WdISIZue4GvXRNvib0K90ufdeseme6w9hJKWoZSFlBg0cVibERxVibQDOiczibGkgQQxuEg/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1" data-type="gif" data-w="600" width="240" src="https://mmbiz.qpic.cn/mmbiz/CItRLtZlHnDZbmxkcWD2WdISIZue4GvXRNvib0K90ufdeseme6w9hJKWoZSFlBg0cVibERxVibQDOiczibGkgQQxuEg/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1"></section></section></section></section></section></section></section></section></section></section></section><p><br></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/QlfeVXs08SFeGI8bobuTQQ",target="_blank" rel="noopener noreferrer">原文链接</a>
